Roy Dennis Bloom - Faculty Biosketch

Roy Dennis Bloom, MBBCh.

Professor of Medicine at the Hospital of the University of Pennsylvania

Department: Medicine

Contact information

One Founders Pavilion
3400 Spruce Street
Philadelphia, Pa 19104-6144

Office: (215) 662-4643
Fax: (215) 615-0349

Education:
BSc (Physiology and Biochemistry)
University of Witwatersrand, 1980.
M.B.B.Ch.
University of Witwatersrand, 1983.

Links
Penn's Renal-Electrolyte and Hypertension Division
Renal-Electrolyte and Hypertension Clinical Trials--Kidney Transplant
Penn Kidney Transplant Program
Renal-Electrolyte and Hypertension Research Interests--Nephrology Clinical Research

Post-Graduate Training
Intern in Medicine and General Surgery, (6 mos. each) , Johannesburg Hospital, South Africa, 1984-1984.
Senior House Officer, Cardiothoracics , Guy's Hospital, London, UK , 1985-1985.
Senior House Officer, Internal Medicine, Hammersmith Hospital, London, 1985-1986.
Senior House Officer, Internal Medicine, Royal Free Hospital, London, UK, 1986-1987.
Intern & Resident, Internal Medicine , Albert Einstein Medical Center, Phila, PA , 1987-1990.
Senior House Officer, Nephrology, St. Phillip's & St. Paul's Hospitals, London, UK, 1987-1987.
Fellow in Renal Medicine, Brigham & Women's Hospital and Harvard University, Boston, MA , 1990-1992.
Fellowship, Renal Electrolyte & Hypertension Division, Hospital of the University of Pennsylvania, Phila, PA, 1992-1994.

Certifications
American Board of Internal Medicine - Nephrology Recertification, 2007.
American Board of Internal Medicine - Nephrology Recertification, 2017.

Permanent link

> Perelman School of Medicine > Faculty > Details

Selected Publications

Lim MA, Kamili S, Cohen JB, Green-Montfort T, Tejada-Strop A, Kohli J, Drobeniuc J, Patel P, Vanderveen M, Bloom RD.: Hepatitis E Virus Infection in Kidney Transplant Patients: A Single-Center Study. Transplantation 102(4): e126-e127, April 2018.

McCauley M, Mussell A, Goldberg D, Sawinski D, Molina RN, Tomlin R, Doshi SD, Abt P, Bloom R, Blumberg E, Kulkarni S, Esnaola G, Shults J, Thiessen C, Reese PP.: Race, Risk, and Willingness of End-Stage Renal Disease Patients Without Hepatitis C Virus to Accept an HCV-Infected Kidney Transplant. Transplantation 102(4): e163-e170, April 2018.

Trofe-Clark J, Brennan DC, West-Thielke P, Milone MC, Lim MA, Neubauer R, Nigro V, Bloom RD: Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate Release Tacrolimus versus Extended Release Tacrolimus in African American Kidney Transplant Recipients American Journal of Kidney Diseases 71(3): 315-326, March 2018.

Bloom R, Varga A, Johnson D, Sawinski D, Lim M, Abt P, Goral S, Bleicher M, Levine M, Naji A, Nazarian S, Porrett P, Trofe-Clark J: "Safety and Feasibility of Outpatient Rabbit Antithymocyte Globulin Induction Therapy Administration in Kidney Transplant Recipients" Pharmacotherapy (in press) 2018.

Potluri VS, Bloom RD: Treating Hepatitis C Virus in Patients with Advanced CKD in the Real-World: Time to Refocus on What Our Real Treatment Goals Should Be. Kidney International (in press) 2018.

Levitsky J, Formica RN, Bloom RD, Charlton M, Curry M, Friedewald J, Friedman J, Goldberg D, Hall S, Ison M, Kaiser T, Klassen D, Klintmalm G, Kobashigawa J, Liapakis A, O'Conner K, Reese P, Shelat K, Stewart D, Terrault N, Theodoropoulos N, Trotter J, Verna E, Volk M: The American Society of transplantation consensus conference on the use of hepatitis C viremic donors in solid organ transplantation. American Journal of Transplantation 17(11): 2790-2802, November 2017.

Hogan JJ, Lim MA, Palmer MB, Bloom RD, Chung RT, Sise ME: Development of proteinuria and focal segmental glomerulosclerosis during direct acting antiviral therapy for hepatitis C virus infection. Hepatology 66(2): 658-660, August 2017.

Bloom RD, Bromberg JS, Poggio E, Bunnapradist S, Langone A, Sood P, Matas A, Mehta S, Sharfuddin A, Fischbach B, Narayanan M, Jordan S, Cohen D, Hiller D, Prasad P, Woodward R, Grskovic M, Sninsky J, Yee JP and Brennan DC: Cell-free DNA and Active Rejection in Kidney Allografts. Journal of the American Society of Nephrology 28(7): 2221-2232, July 2017.

Koyawala N, Silber JH, Rosenbaum PR, Wang W,Hill AS, Reiter JG, Niknam BA, Even-Shoshan O,Bloom RD, Sawinski D, Nazarian S, Trofe-Clark J, Lim MA, Schold J, Reese PP : Comparing outcomes between antibody induction therapies in kidney transplantation. Journal of the American Society of Nephrology 28(7): 2188-2220, July 2017.

Sawinski D, Patel N, Appolo B, Bloom RD: Use of HCV+ donors does not affect HCV clearance with directly acting antiviral therapy but shortens the wait time to kidney transplantation. Transplantation 101(5), May 2017.